Zallot C - Search Results

1

Self-insertion of a nasogastric tube for home enteral nutrition: a pilot study.

Quilliot D, Zallot C, Malgras A, Germain A, Bresler L, Ayav A, Bigard MA, Peyrin-Biroulet L, Ziegler O. Quilliot D, et al. Among authors: zallot c. JPEN J Parenter Enteral Nutr. 2014 Sep;38(7):895-900. doi: 10.1177/0148607113502544. Epub 2013 Oct 18. JPEN J Parenter Enteral Nutr. 2014. PMID: 24142673

2

Dietary beliefs and behavior among inflammatory bowel disease patients.

Zallot C, Quilliot D, Chevaux JB, Peyrin-Biroulet C, Guéant-Rodriguez RM, Freling E, Collet-Fenetrier B, Williet N, Ziegler O, Bigard MA, Guéant JL, Peyrin-Biroulet L. Zallot C, et al. Inflamm Bowel Dis. 2013 Jan;19(1):66-72. doi: 10.1002/ibd.22965. Inflamm Bowel Dis. 2013. PMID: 22467242

3

5-Aminosalicylates and renal function monitoring in inflammatory bowel disease: a nationwide survey.

Zallot C, Billioud V, Frimat L, Faure P, Peyrin-Biroulet L; CREGG (Club de Reflexion des cabinets et Groupes d'Hépato-Gastroentérologie). Zallot C, et al. J Crohns Colitis. 2013 Aug;7(7):551-5. doi: 10.1016/j.crohns.2012.08.013. Epub 2012 Sep 21. J Crohns Colitis. 2013. PMID: 22999780

4

Clinical risk factors for complicated disease: how reliable are they?

Zallot C, Peyrin-Biroulet L. Zallot C, et al. Dig Dis. 2012;30 Suppl 3:67-72. doi: 10.1159/000342608. Epub 2013 Jan 3. Dig Dis. 2012. PMID: 23295694 Review.

5

Deep remission in inflammatory bowel disease: looking beyond symptoms.

Zallot C, Peyrin-Biroulet L. Zallot C, et al. Curr Gastroenterol Rep. 2013 Mar;15(3):315. doi: 10.1007/s11894-013-0315-7. Curr Gastroenterol Rep. 2013. PMID: 23354742 Review.

6

Impact of immunosuppressive therapy on hepatitis B vaccination in inflammatory bowel diseases.

Belle A, Baumann C, Bigard MA, Zallot C, Gizard E, Guéant JL, Bronowicki JP, Peyrin-Biroulet L. Belle A, et al. Among authors: zallot c. Eur J Gastroenterol Hepatol. 2015 Aug;27(8):877-81. doi: 10.1097/MEG.0000000000000370. Eur J Gastroenterol Hepatol. 2015. PMID: 26121376

7

Cancer Immunotherapy with Anti-CTLA-4 Monoclonal Antibodies Induces an Inflammatory Bowel Disease.

Marthey L, Mateus C, Mussini C, Nachury M, Nancey S, Grange F, Zallot C, Peyrin-Biroulet L, Rahier JF, Bourdier de Beauregard M, Mortier L, Coutzac C, Soularue E, Lanoy E, Kapel N, Planchard D, Chaput N, Robert C, Carbonnel F. Marthey L, et al. Among authors: zallot c. J Crohns Colitis. 2016 Apr;10(4):395-401. doi: 10.1093/ecco-jcc/jjv227. Epub 2016 Jan 18. J Crohns Colitis. 2016. PMID: 26783344 Free PMC article.

8

Prevalence of Bowel Damage Assessed by Cross-Sectional Imaging in Early Crohn's Disease and its Impact on Disease Outcome.

Fiorino G, Morin M, Bonovas S, Bonifacio C, Spinelli A, Germain A, Laurent V, Zallot C, Peyrin-Biroulet L, Danese S. Fiorino G, et al. Among authors: zallot c. J Crohns Colitis. 2017 Mar 1;11(3):274-280. doi: 10.1093/ecco-jcc/jjw185. J Crohns Colitis. 2017. PMID: 27799269

9

Accuracy of Diffusion-weighted Magnetic Resonance Colonography in Assessing Mucosal Healing and the Treatment Response in Patients with Ulcerative Colitis.

Laurent V, Naudé S, Vuitton L, Zallot C, Baumann C, Girard-Gavanier M, Peyrin-Biroulet L. Laurent V, et al. Among authors: zallot c. J Crohns Colitis. 2017 Jun 1;11(6):716-723. doi: 10.1093/ecco-jcc/jjw211. J Crohns Colitis. 2017. PMID: 27932450

10

Early changes in the pharmacokinetic profile of vedolizumab-treated patients with IBD may predict response after dose optimisation.

Gouynou C, Pouillon L, Rousseau H, Zallot C, Baumann C, Peyrin-Biroulet L. Gouynou C, et al. Among authors: zallot c. Gut. 2019 Jan;68(1):178-179. doi: 10.1136/gutjnl-2017-315766. Epub 2018 Jan 13. Gut. 2019. PMID: 29331941 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

49 results

Search Page